Evidence map›Paper›PMID 31160516›Full record

ArticleJournal of the American Society of Nephrology : JASN2019

Authors' Reply.

Magdalene M Assimon, Jennifer E Flythe

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Magdalene M AssimonUniversity of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina; and massimon@med.unc.edu.
Jennifer E FlytheUniversity of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina; and.

Funding

Investigating strategies to reduce fluid-related complications among hemodialysis patientsK23DK109401 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FLYTHE, JENNIFER E · 2016 to 2020
$992k
Investigating the comparative cardiac safety of selective serotonin reuptake inhibitors in the hemodialysis populationR03HS026801 · AHRQ · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ASSIMON, MAGDALENE MARIE · 2019 to 2020
$99k
AHRQ HHS R03 HS026801NIDDK NIH HHS K23 DK109401
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Renal DialysisSelective Serotonin Reuptake InhibitorsDeath, Sudden, CardiacHeartHumansSelective Serotonin Reuptake InhibitorsdepressionhemodialysissafetySSRIssudden cardiac death

Identifiers

PMID31160516
PMCPMC6622419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.